viemed healthcare inc - VMD

VMD

Close Chg Chg %
10.01 -0.17 -1.70%

Closed Market

9.84

-0.17 (1.70%)

Volume: 278.67K

Last Updated:

May 29, 2026, 4:00 PM EDT

Company Overview: viemed healthcare inc - VMD

VMD Key Data

Open

$10.00

Day Range

9.81 - 10.02

52 Week Range

5.93 - 10.18

Market Cap

$383.75M

Shares Outstanding

38.34M

Public Float

33.10M

Beta

1.15

Rev. Per Employee

N/A

P/E Ratio

26.64

EPS

$0.39

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

266.60K

 

VMD Performance

1 Week
 
1.97%
 
1 Month
 
-1.30%
 
3 Months
 
13.10%
 
1 Year
 
47.97%
 
5 Years
 
25.99%
 

VMD Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About viemed healthcare inc - VMD

Viemed Healthcare, Inc. engages in the provision of home healthcare solutions. Through its subsidiaries, it supplies home medical equipment which provides post-acute respiratory services. It also offers respiratory disease management and in-home sleep testing and sleep apnea treatment. The company was founded by Casey Hoyt, Max Hoyt, and Michael Moore in 2016 and is headquartered in Lafayette, LA.

VMD At a Glance

Viemed Healthcare, Inc.
625 East Kaliste Saloom Road
Lafayette, Louisiana 70508
Phone 1-337-504-3802 Revenue 270.28M
Industry Hospital/Nursing Management Net Income 14.93M
Sector Health Services 2025 Sales Growth 20.522%
Fiscal Year-end 12 / 2026 Employees 1,382
View SEC Filings

VMD Valuation

P/E Current 26.644
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 20.312
Price to Sales Ratio 1.122
Price to Book Ratio 1.996
Price to Cash Flow Ratio 5.84
Enterprise Value to EBITDA 6.10
Enterprise Value to Sales 1.139
Total Debt to Enterprise Value 0.052

VMD Efficiency

Revenue/Employee 195,571.635
Income Per Employee 10,806.078
Receivables Turnover 10.471
Total Asset Turnover 1.379

VMD Liquidity

Current Ratio 1.181
Quick Ratio 1.058
Cash Ratio 0.329

VMD Profitability

Gross Margin 56.968
Operating Margin 8.078
Pretax Margin 8.054
Net Margin 5.525
Return on Assets 7.619
Return on Equity 10.943
Return on Total Capital 9.482
Return on Invested Capital 10.222

VMD Capital Structure

Total Debt to Total Equity 11.267
Total Debt to Total Capital 10.126
Total Debt to Total Assets 7.42
Long-Term Debt to Equity 9.647
Long-Term Debt to Total Capital 8.67
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Viemed Healthcare Inc - VMD

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
138.83M 183.01M 224.26M 270.28M
Sales Growth
+18.60% +31.82% +22.54% +20.52%
Cost of Goods Sold (COGS) incl D&A
55.16M 71.62M 92.54M 116.31M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
15.63M 21.89M 24.00M 28.61M
Depreciation
15.63M 21.82M 23.90M 27.10M
Amortization of Intangibles
- 75.00K 100.00K 1.51M
COGS Growth
+23.96% +29.82% +29.21% +25.69%
Gross Income
83.67M 111.39M 131.72M 153.97M
Gross Income Growth
+15.31% +33.14% +18.25% +16.89%
Gross Profit Margin
+60.27% +60.87% +58.74% +56.97%
2022 2023 2024 2025 5-year trend
SG&A Expense
76.06M 95.98M 115.20M 132.39M
Research & Development
2.70M 2.78M 3.07M 3.02M
Other SG&A
73.36M 93.19M 112.13M 129.37M
SGA Growth
+22.37% +26.19% +20.03% +14.92%
Other Operating Expense
(989.00K) (98.00K) 173.00K (252.00K)
Unusual Expense
(935.00K) 53.00K 354.00K 1.12M
EBIT after Unusual Expense
9.53M 15.46M 16.00M 20.71M
Non Operating Income/Expense
(346.00K) (645.00K) 951.00K 2.24M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - (954.00K)
-
Interest Expense
197.00K 424.00K 776.00K 1.18M
Interest Expense Growth
-38.05% +115.23% +83.02% +52.32%
Gross Interest Expense
197.00K 424.00K 776.00K 1.18M
Interest Capitalized
- - - -
-
Pretax Income
8.99M 14.39M 16.17M 21.77M
Pretax Income Growth
-28.10% +60.08% +12.36% +34.61%
Pretax Margin
+6.48% +7.86% +7.21% +8.05%
Income Tax
2.77M 4.15M 4.76M 6.39M
Income Tax - Current - Domestic
1.02M 5.59M 8.60M 3.28M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
1.75M (1.44M) (3.84M) 3.11M
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - (954.00K)
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
6.22M 10.24M 11.41M 15.38M
Minority Interest Expense
- - 144.00K 442.00K
-
Net Income
6.22M 10.24M 11.27M 14.93M
Net Income Growth
-31.82% +64.63% +9.98% +32.57%
Net Margin Growth
+4.48% +5.60% +5.02% +5.53%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
6.22M 10.24M 11.27M 14.93M
Preferred Dividends
- - - -
-
Net Income Available to Common
6.22M 10.24M 11.27M 14.93M
EPS (Basic)
0.161 0.2671 0.2907 0.384
EPS (Basic) Growth
-30.33% +65.90% +8.84% +32.09%
Basic Shares Outstanding
38.66M 38.35M 38.75M 38.90M
EPS (Diluted)
0.1563 0.2537 0.2761 0.3658
EPS (Diluted) Growth
-30.32% +62.32% +8.83% +32.49%
Diluted Shares Outstanding
39.81M 40.38M 40.81M 40.82M
EBITDA
24.23M 37.40M 40.35M 50.45M
EBITDA Growth
+3.80% +54.38% +7.87% +25.03%
EBITDA Margin
+17.45% +20.44% +17.99% +18.66%

Snapshot

Average Recommendation BUY Average Target Price 13.00
Number of Ratings 1 Current Quarters Estimate 0.12
FY Report Date 06 / 2026 Current Year's Estimate 0.455
Last Quarter’s Earnings 0.06 Median PE on CY Estimate N/A
Year Ago Earnings 0.37 Next Fiscal Year Estimate 0.61
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 2 2 2 2
Mean Estimate 0.12 0.13 0.46 0.61
High Estimates 0.14 0.13 0.47 0.64
Low Estimate 0.10 0.13 0.44 0.58
Coefficient of Variance 23.57 0.00 4.66 6.96

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 2
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Viemed Healthcare Inc in the News